Facebook
Twitter
Telegram
Report an ErrorConcert Pharmaceuticals Financial Statements 2011-2024 | CNCE
Annual Financial Statements Concert Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
103 M | 327 M | 259 M | 333 M | 477 M | 199 M | 323 M | 209 M | - | - | - |
Shares |
34.4 M | 31.2 M | 23.7 M | 23.4 M | 22.6 M | 22.2 M | 21.2 M | 15.8 M | - | - | - |
Historical Prices |
3.03 | 10.5 | 10.7 | 14.2 | 20.1 | 8.85 | 15.3 | 13.2 | - | - | - |
Net Income |
-80.1 M | -74.8 M | -78.2 M | -56 M | 95.6 M | -50.7 M | 24.2 M | -31.7 M | -6.06 M | -20.4 M | -11.3 M |
Revenue |
- | 7.9 M | 1.08 M | 10.5 M | 144 M | 174 K | 66.7 M | 8.58 M | 25.4 M | 12.8 M | 19.5 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 7.9 K | - | - | - | - | 66.7 M | 8.58 M | 25.4 M | 12.8 M | - |
Operating Income |
-77.5 M | -72.6 M | -79 M | -55.6 M | 92.6 M | -51.2 M | 24.8 M | -30.6 M | -4.41 M | -18.6 M | - |
Interest Expense |
- | - | - | - | - | - | -309 K | -1.15 M | -1.67 M | -1.86 M | - |
EBITDA |
-76 M | -72.3 M | -78.7 M | -54.3 M | 93.7 M | -50.3 M | 25.6 M | -29.5 M | -3.06 M | -17.2 M | -9.73 M |
Operating Expenses |
110 M | 80.5 M | 80.1 M | 66.1 M | 51.2 M | 51.3 M | 41.9 M | 39.2 M | 29.8 M | 31.5 M | 30.8 M |
General and Administrative Expenses |
22.5 M | 18.6 M | 20 M | 22.9 M | 21 M | 14.4 M | 13.1 M | 11.7 M | 8.03 M | 7.27 M | 7.38 M |
All numbers in USD currency
Quarterly Income Statement Concert Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 49.7 M | - | 36.7 M | 34.7 M | 34.1 M | 34 M | 33.9 M | 31.9 M | 31.5 M | 31.5 M | 29.1 M | 23.9 M | 23.8 M | 23.8 M | 23.5 M | 23.4 M | 23.4 M | 23.4 M | 23.2 M | 23.1 M | 22.7 M | 22.6 M | 22.4 M | 22.3 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 21.9 M | 21.8 M | 18.7 M | 18.2 M | 18.1 M | 17.9 M | 9.19 M | 1.3 M | 1.29 M | 1.29 M | 1.29 M | - | - | - | - | - | - | - | - |
Net Income |
- | -28.9 M | -23.5 M | -37.7 M | - | -26.7 M | 5.42 M | -22.7 M | -22.4 M | -18.9 M | -13 M | -20.5 M | -20.5 M | -17.2 M | -18.7 M | -21.8 M | -20.8 M | -17.4 M | -13.3 M | -4.46 M | -6.07 M | 128 M | -13 M | -13.3 M | -12 M | -11.4 M | -13.4 M | -13.9 M | 684 K | -8.55 M | 41 M | -9 M | -8.93 M | -7.83 M | -7.99 M | -6.95 M | -5.92 M | -7.13 M | 8.76 M | -1.78 M | - | - | - | - | - | - | - | - |
Revenue |
- | 8 K | - | - | - | 543 K | 32 M | 5 K | 7 K | 1.5 M | 6.39 M | 7 K | 13 K | 10 K | 49 K | 1 M | 13 K | 11 K | 2 K | 10.5 M | 12 K | 144 M | 15 K | 20 K | 21 K | 26 K | 71 K | 56 K | 10.3 M | 1.71 M | 53.4 M | 1.31 M | 1.31 M | 4.42 M | 1.24 M | 1.61 M | 1.41 M | 681 K | 17.4 M | 5.87 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -29.6 M | - | -36 M | - | -26.8 M | 6.22 M | -24 M | -21.5 M | -19.4 M | -13.1 M | -18.7 M | -21 M | -18.2 M | -19.4 M | -20.4 M | -20.1 M | -17.3 M | -14.4 M | -3.81 M | -12.7 M | 132 M | -13 M | -13.5 M | -12.2 M | -11.5 M | -13.6 M | -14 M | 663 K | -8.69 M | 41.7 M | -8.87 M | -8.74 M | -7.61 M | -7.73 M | -6.52 M | -5.58 M | -7.12 M | 9.42 M | -1.13 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -609 K | -205 K | - | - | - | - | - | - | -58 K | -103 K | -148 K | - | -239 K | -280 K | -435 K | - | -14 K | -653 K | -660 K | - | - | - | - | - | - | - | - |
EBITDA |
- | -28.7 M | - | -35.7 M | - | -25.6 M | 6.22 M | -23.6 M | -21.5 M | -18.2 M | -12.3 M | -18.2 M | -21 M | -17 M | -18.6 M | -20 M | -20.1 M | -16.5 M | -13.9 M | -3.55 M | -12.7 M | 133 M | -12.5 M | -13.2 M | -12.2 M | -10.8 M | -13.1 M | -13.8 M | 663 K | -8.12 M | 42.1 M | -8.69 M | -8.74 M | -6.63 M | -7.08 M | -6.19 M | -5.58 M | -6.11 M | 10.1 M | -792 K | - | - | - | - | - | - | - | - |
Operating Expenses |
- | 29.6 M | - | 36 M | - | 27.3 M | 25.8 M | 24 M | 21.5 M | 20.9 M | 19.5 M | 18.7 M | 21 M | 18.3 M | 19.5 M | 21.4 M | 20.1 M | 17.4 M | 14.4 M | 14.3 M | 12.7 M | 12 M | 13 M | 13.5 M | 12.2 M | 11.5 M | 13.6 M | 14 M | 9.64 M | 10.4 M | 11.7 M | 10.2 M | 10.1 M | 12 M | 8.96 M | 8.13 M | 6.99 M | 7.8 M | 8.03 M | 7 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | 5.25 M | - | 5.54 M | - | 5.46 M | 5.61 M | 5.48 M | - | 4.51 M | 4.73 M | 4.67 M | - | 4.74 M | 4.98 M | 5.61 M | - | 6.32 M | 5.51 M | 5.63 M | - | 4.88 M | 5.71 M | 5.25 M | - | 3.44 M | 3.83 M | 3.58 M | - | 3.27 M | 3.3 M | 3.23 M | - | 3.46 M | 2.72 M | 2.54 M | - | 2.13 M | 2.27 M | 1.96 M | - | - | - | - | - | - | - | - |
All numbers in USD currency